| Meeting Details | |
| Speaker: | Professor Sarah Dimeloe |
| Affiliation: | University of Birmingham |
| Date: | Thursday, 4th February 2027 |
| Time: | |
| Venue: | University of Birmingham |
| Description: | Many new cancer therapies aim to take advantage of the capacity of certain of our white blood cells (called T cells) to target and kill cancer cells. Dr. Dimeloe oversees a team that studies killer T cells to understand how they respond to these therapies and identify barriers that could be overcome to improve treatment responses. She will also discuss her recent research on Multiple Myeloma, a blood cancer. |
Share
10
AUG
AUG
0